12/5
05:15 pm
nvax
Novavax, Inc. (NVAX): A Bull Case Theory [Yahoo! Finance]
Low
Report
Novavax, Inc. (NVAX): A Bull Case Theory [Yahoo! Finance]
12/1
03:01 pm
nvax
Pharma Stocks Fall After Leaked Memo Questions Vaccine Safety [Barron's]
Low
Report
Pharma Stocks Fall After Leaked Memo Questions Vaccine Safety [Barron's]
12/1
12:17 pm
nvax
Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino [Yahoo! Finance Canada]
Low
Report
Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino [Yahoo! Finance Canada]
12/1
10:03 am
nvax
Moderna Falls as FDA Vows to Impose New Vaccine Requirements [Yahoo! Finance Canada]
Low
Report
Moderna Falls as FDA Vows to Impose New Vaccine Requirements [Yahoo! Finance Canada]
11/29
01:46 pm
nvax
FDA official, without providing data, claims link between COVID-19 vaccines and pediatric deaths [CBS News]
Medium
Report
FDA official, without providing data, claims link between COVID-19 vaccines and pediatric deaths [CBS News]
11/26
12:13 pm
nvax
Milestones Over Sales: The Sanofi Partnership Now Drives Novavax's Outlook [Seeking Alpha]
Low
Report
Milestones Over Sales: The Sanofi Partnership Now Drives Novavax's Outlook [Seeking Alpha]
11/26
08:41 am
nvax
Novavax's R&D Shift and Sanofi Partnership Could Be a Game Changer for NVAX [Yahoo! Finance]
Medium
Report
Novavax's R&D Shift and Sanofi Partnership Could Be a Game Changer for NVAX [Yahoo! Finance]
11/25
08:51 am
nvax
Novavax Shifts From COVID Sales to R&D Focus While Updating 2025 Forecast [Yahoo! Finance]
Low
Report
Novavax Shifts From COVID Sales to R&D Focus While Updating 2025 Forecast [Yahoo! Finance]
11/21
02:16 pm
nvax
Novavax rises after a seven-day slide [Seeking Alpha]
Low
Report
Novavax rises after a seven-day slide [Seeking Alpha]
11/21
01:05 pm
nvax
Novamax rises after a seven-day slide [Seeking Alpha]
Low
Report
Novamax rises after a seven-day slide [Seeking Alpha]
11/18
11:04 am
nvax
Novavax (NASDAQ:NVAX) had its price target lowered by analysts at JPMorgan Chase & Co. from $7.00 to $6.00. They now have an "underweight" rating on the stock.
Low
Report
Novavax (NASDAQ:NVAX) had its price target lowered by analysts at JPMorgan Chase & Co. from $7.00 to $6.00. They now have an "underweight" rating on the stock.
11/12
04:54 pm
nvax
Shah Capital pushes for Novavax sale, warns of proxy fight [Yahoo! Finance]
Low
Report
Shah Capital pushes for Novavax sale, warns of proxy fight [Yahoo! Finance]
11/12
08:00 am
nvax
Novavax to Participate in Jefferies London Healthcare Conference
Medium
Report
Novavax to Participate in Jefferies London Healthcare Conference
11/10
11:05 am
nvax
Novavax (NASDAQ:NVAX) had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $16.00 price target on the stock, down previously from $18.00.
Low
Report
Novavax (NASDAQ:NVAX) had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $16.00 price target on the stock, down previously from $18.00.
11/9
02:53 am
nvax
Examining the Changing Narrative for Novavax After Recent Partnerships and Strategic Shifts [Yahoo! Finance]
Medium
Report
Examining the Changing Narrative for Novavax After Recent Partnerships and Strategic Shifts [Yahoo! Finance]
11/8
01:17 pm
nvax
Medium
Report
11/6
08:00 am
nvax
Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights
Low
Report
Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights
11/5
04:49 pm
nvax
A Look at Novavax's Valuation Following U.S. Vaccine Rights Transfer to Sanofi (NVAX) [Yahoo! Finance]
Low
Report
A Look at Novavax's Valuation Following U.S. Vaccine Rights Transfer to Sanofi (NVAX) [Yahoo! Finance]
11/4
02:03 pm
nvax
Novavax (NASDAQ:NVAX) had its price target lowered by analysts at TD Cowen from $8.00 to $7.00. They now have a "hold" rating on the stock.
Low
Report
Novavax (NASDAQ:NVAX) had its price target lowered by analysts at TD Cowen from $8.00 to $7.00. They now have a "hold" rating on the stock.
11/4
07:00 am
nvax
Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment
Medium
Report
Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment
10/30
08:00 am
nvax
Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025
Low
Report
Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025
10/25
11:32 pm
nvax
How the Narrative Around Novavax Is Shifting With New Partnerships and Strategic Changes [Yahoo! Finance]
Low
Report
How the Narrative Around Novavax Is Shifting With New Partnerships and Strategic Changes [Yahoo! Finance]
10/24
09:02 am
nvax
Novavax (NASDAQ:NVAX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $18.00 price target on the stock.
Low
Report
Novavax (NASDAQ:NVAX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $18.00 price target on the stock.
10/23
10:00 am
nvax
Novavax (NASDAQ:NVAX) had its price target raised by analysts at HC Wainwright from $10.00 to $11.00. They now have a "buy" rating on the stock.
Low
Report
Novavax (NASDAQ:NVAX) had its price target raised by analysts at HC Wainwright from $10.00 to $11.00. They now have a "buy" rating on the stock.
10/22
07:00 am
nvax
Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy
Low
Report
Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy